Posted on

ENT & Allergy Associates Expands Pennsylvania Footprint with Melissa Schwartz, DO, and New Elkins Park Clinical Site

ENT & Allergy Associates of Pennsylvania today announced the addition of otolaryngologist Melissa Schwartz, DO, and her established clinical practice at 375 Township Line Road in Elkins Park, PA, effective January 1, 2027. 

ENT & Allergy Associates of Pennsylvania today announced the addition of otolaryngologist Melissa Schwartz, DO, and her established clinical practice at 375 Township Line Road in Elkins Park, PA, effective January 1, 2027.

By sf-admin
Posted on

Italfarmaco Presents New Givinostat (Duvyzat®) Clinical Data Supporting Preservation of Upper Limb Function in Duchenne Muscular Dystrophy Patients at the 2026 World Muscle Society Congress

MILAN, Italy, September 30, 2026 – Italfarmaco S.p.A. today announced new long-term data from the ongoing Phase 3 EPIDYS open-label extension (OLE) study showing that treatment with givinostat (Duvyzat®) may help preserve upper limb function in boys with Duchenne muscular dystrophy (DMD). The findings, presented at the 31st Annual International Congress of the World Muscle Society (WMS), provide further evidence supporting the long-term clinical benefits of givinostat across multiple measures of disease progression.

John Brandsema, MD, Paediatric Neurologist in the Division of Neurology at Children’s Hospital of Philadelphia, presented the poster “Trajectory of Performance of Upper Limb in Patients With Duchenne Muscular Dystrophy Treated With Givinostat Relative to a Modeled Natural History Cohort from a Single Centre,” which compared upper limb function in givinostat-treated patients with counterfactual trajectories estimated from an external natural history-based model representing predicted disease progression in the absence of treatment, using the Performance of Upper Limb 2.0 (PUL 2.0) assessment. Upper limb function is an increasingly important measure of disease progression as DMD advances and loss of ambulation occurs.

“Preserving upper limb function is critically important for people living with Duchenne because it directly affects independence and the ability to perform everyday activities,” said Scott Baver, PhD, VP, Head of Global Medical Affairs, Rare Diseases. “These new findings extend our understanding of givinostat beyond ambulatory outcomes and provide exploratory evidence suggesting a potential effect on the preservation of upper limb function, an important aspect of disease progression for people living with DMD.”

“Upper limb function becomes increasingly important as Duchenne progresses because it has a direct impact on independence and participation in daily life,” said John Brandsema, MD, Paediatric Neurologist at Children’s Hospital of Philadelphia and presenter of the analysis. “Preserving upper limb function is an outcome that matters greatly to patients and families.” 

Key findings:
These exploratory analyses compared observed outcomes in patients receiving givinostat with predicted outcomes generated from an external natural history-based model and should be interpreted within the context of this study design.

By sf-admin
Posted on

Silicon Anode Materials Market Size to Hit USD 44.16 Billion by 2035 at 42.62% CAGR | SNS Insider

SNS Insider Estimates, the Silicon Anode Materials Market is projected to reach USD 44.16 billion by 2035, growing at a 42.62% CAGR, while the U.S. market is projected to reach USD 8.00 billion, advancing at 40.60% CAGR, as battery makers pursue higher energy density. 

SNS Insider Estimates, the Silicon Anode Materials Market is projected to reach USD 44.16 billion by 2035, growing at a 42.62% CAGR, while the U.S. market is projected to reach USD 8.00 billion, advancing at 40.60% CAGR, as battery makers pursue higher energy density.

By sf-admin
Posted on

MT Højgaard Holding A/S: MT Højgaard Danmark acquires Nordisk Fundering

MT Højgaard Holding’s business MT Højgaard Danmark has entered into an agreement to acquire 100% of the shares in the Danish foundation engineering specialist Nordisk Fundering A/S. The purchase price for the shares is DKK 52 million (enterprise value), of which DKK 16 million is an earn-out and thus contingent upon future conditions. The acquisition is subject to approval by competition authorities and is expected to be completed during Q4 2026.

By sf-admin
Posted on

MT Højgaard Holding A/S: MT Højgaard Danmark køber Nordisk Fundering

MT Højgaard Holdings forretningsenhed MT Højgaard Danmark har indgået aftale om at købe 100% af aktierne i den danske funderingsspecialist Nordisk Fundering A/S. Købsprisen for aktierne er 52 mio. kr. (enterprise value), hvoraf 16 mio. kr. er earn-out og derved betinget af fremtidige forhold. Købet er betinget af konkurrencemyndighedernes godkendelse og ventes endeligt gennemført i løbet af 4. kvartal 2026.

By sf-admin
Posted on

Chacun fait bien son travail, et l’entreprise répond cinq fois à la même question

Dans une entreprise, la conformité n’est pas tenue par une personne : elle est répartie entre une dizaine de responsables. Cette répartition produit une conséquence que personne n’observe, parce que personne ne la subit en entier. La même information y est établie plusieurs fois, par des équipes différentes, et le coût de la conformité tient moins au nombre de règles qu’à cette répétition invisible.

By sf-admin
Posted on

Terumo Neuro Signs Agreement to Acquire Arsenal Medical – Advancing Next-Generation Liquid Embolic Innovation for Treating Chronic Subdural Hematoma (cSDH)

Proposed acquisition would add NeoCast™, an investigational technology designed for controlled delivery and predictable distal penetration, to Terumo Neuro’s neurovascular portfolio. 

Proposed acquisition would add NeoCast™, an investigational technology designed for controlled delivery and predictable distal penetration, to Terumo Neuro’s neurovascular portfolio.

By sf-admin
Posted on

Apollo Funds Announce Completion of Acquisition of Nippon Sheet Glass, Marking New Chapter of Growth

TOKYO and NEW YORK, Sept. 29, 2026 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced the successful completion of Apollo managed funds’ (“Apollo Funds”) acquisition of Nippon Sheet Glass Co., Ltd., a leading global company in architectural, automotive, and solar glass, and the launch of its new management structure, marking the new beginning of its next phase of growth.

By sf-admin
Posted on

E-Power Inc. Announces Pricing of Approximately $1.87 Million Registered Direct Offering

DOVER, USA, Sept. 29, 2026 (GLOBE NEWSWIRE) — E-Power Inc. (the “Company” or “E-Power”) (NASDAQ: EPOW), a provider of AI Data Center (AIDC) microgrid solutions and advanced battery materials, today announced that it has entered into a securities purchase agreement with a certain non-U.S. investor to purchase approximately $1.87 million of its Class A ordinary shares (the “Ordinary Shares”) (and pre-funded warrants in lieu thereof) in a registered direct offering.

By sf-admin